Prostate Cancer Resource Center
Featured Content

A collection of timely studies, news, treatment options and more is presented in this concise, invaluable resource.

Resource Library

Choosing a Practice or Choosing a Partner?

Salary Survey reviews options and salary by state for making the transition to private practice…March 2019, AAOS Career Center Feature

Read More

Factors Motivating Medical Students in Selecting a Career Specialty: Relevance for a Robust Orthopaedic Pipeline

Research Article. Journal of the American Academy of Orthopaedic Surgeons. 

Read More

Two Year or Four Year Fellowship

The Impact on early stage career growth and salary. July 2019, AAOS Career Center Feature.

Read More

Surveys

FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer

The FDA approved a supplemental New Drug Application (sNDA) for enzalutamide, following FDA Priority Review designation, based on results from the phase III PROSPER trial. The FDA action broadens the indication for enzalutamide to men with castration-resistant prostate cancer (CRPC), now including men with non-metastatic CRPC.

Read More

FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer

The FDA approved a supplemental New Drug Application (sNDA) for enzalutamide, following FDA Priority Review designation, based on results from the phase III PROSPER trial. The FDA action broadens the indication for enzalutamide to men with castration-resistant prostate cancer (CRPC), now including men with non-metastatic CRPC.

Read More

  More Surveys

 

  • Salary Survey
  • Work-Life Survey
  • Job Seeker Survey

More Surveys

Prostate Cancer Channel

Brought to you by Oncology Times

A collection of timely studies, news, treatment options and more is presented in this concise, invaluable resource.

Resource Library

Choosing a Practice or Choosing a Partner?

Salary Survey reviews options and salary by state for making the transition to private practice…March 2019, AAOS Career Center Feature

Read More

Factors Motivating Medical Students in Selecting a Career Specialty: Relevance for a Robust Orthopaedic Pipeline

Research Article. Journal of the American Academy of Orthopaedic Surgeons. 

Read More

Two Year or Four Year Fellowship

The Impact on early stage career growth and salary. July 2019, AAOS Career Center Feature.

Read More

Surveys

FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer

The FDA approved a supplemental New Drug Application (sNDA) for enzalutamide, following FDA Priority Review designation, based on results from the phase III PROSPER trial. The FDA action broadens the indication for enzalutamide to men with castration-resistant prostate cancer (CRPC), now including men with non-metastatic CRPC.

Read More

FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer

The FDA approved a supplemental New Drug Application (sNDA) for enzalutamide, following FDA Priority Review designation, based on results from the phase III PROSPER trial. The FDA action broadens the indication for enzalutamide to men with castration-resistant prostate cancer (CRPC), now including men with non-metastatic CRPC.

Read More

  More Surveys

 

  • Salary Survey
  • Work-Life Survey
  • Job Seeker Survey

More Surveys

Prostate Cancer Channel

Brought to you by Oncology Times

Loading